Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties Please visit their website for more information.
*Proprietary Buy Sell Volume Indicator
| Revenue: $5.49B |
| Revenue Growth (YOY): 11.92% |
| Profit (% of Rev): 64.02% |
| Income (% of Rev): 15.18% |
| Income Growth (YOY): 20.52% |
| Operating Income: $1.08B |
| Operating Cash Flow: $1.47B |
| Operating Cash Flow Growth (YoY): 40.38% |
| Annual Dividend Yield: 0.22% |
| Total Assets: $43.83B |
| Total Liabilities: $23.68B |
| Cash & Equivalent: $3.85B |
| Total Debt: $15.48B |
| Debt/Equity: 0.77 |
| Quick Ratio: 1.22 |
| Current Ratio: 1.91 |
| Price/Book: 6.83 |
| Price/Earnings: 41.27 |
| EBITDA: $1.35B |
| EPS: 2.19 |
Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering all the above parameters, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Buy.
TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.
Contact @ support@theoryofstocks.com
© 2024 Stock Articles. All rights reserved.